2-(3-chlorophenyl)propan-2-amine | 17790-50-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(3-chlorophenyl)propan-2-amine
• CAS: 17790-50-0
• 化学式: C₉H₁₂ClN
• mdl: MFCD09904108
• 分子量: 169.654
• InChiKey: RJFOLCUYDLFKFW-UHFFFAOYSA-N

物化性质

• 沸点：
  227.0±15.0 °C(Predicted)
• 密度：
  1.092±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2921499090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-(3-Chlorophenyl)propan-2-amine HCl
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-(3-Chlorophenyl)propan-2-amine HCl
CAS number: 17790-50-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H12ClN.ClH
Molecular weight: 206.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-(3-chlorophenyl)propan-2-amine 在 copper diacetate 、 palladium diacetate 、 copper dichloride 作用下， 以 溶剂黄146 为溶剂， 反应 14.0h， 以82%的产率得到2-(2,5-dichlorophenyl)propan-2-amine
  参考文献：
  名称：

  天然胺导向的邻-C-H 卤化和乙酰氧基化/苄胺的缩合

  摘要：

  众所周知，游离或未官能化的苄胺在钯盐存在下参与 C-H 活化。尽管可以很容易地激活这些配合物，但二聚环金属盐的后续功能化可能具有挑战性。我们在此展示了一种基于游离伯胺的 C-H 活化/功能化方案，该方案允许未保护的苄胺的邻-C-H 氯化和溴化。我们还展示了由于游离伯胺导向基团的亲核性，氟基氧化剂的使用如何产生独特的乙酰氧基化/环化。

  DOI：

  10.1055/a-1625-9095
• 作为产物：
  描述：

  1,4-二异丙基苯 在 盐酸 、 三氯化铝 、 氯化氮 、 溴代叔丁烷 、 氯 、 铁粉 作用下， 以 四氯化碳 、 1,2-二氯乙烷 、 甲苯 为溶剂， 生成 2-(3-chlorophenyl)propan-2-amine
  参考文献：
  名称：

  Chemistry of N-halamines. XI. Side-chain amination of aryldialkylmethines with trichloramine-aluminum chloride-tert-butyl bromide

  摘要：

  DOI：

  10.1021/jo01276a047

文献信息

• SUBSTITUTED BIPIPERIDINYL DERIVATIVES
  申请人：Bayer Pharma Aktiengesellschaft

  公开号：US20160318866A1

  公开（公告）日：2016-11-03

  The invention relates to novel substituted bipiperidinyl derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of diabetic microangiopathies, diabetic ulcers on the extremities, in particular for promoting wound healing of diabetic foot ulcers, diabetic heart failure, diabetic coronary microvascular heart disorders, peripheral and cardiac vascular disorders, thromboembolic disorders and ischaemias, peripheral circulatory disturbances, Raynaud's phenomenon, CREST syndrome, microcirculatory disturbances, intermittent claudication, and peripheral and autonomous neuropathies.

  该发明涉及新型取代的双哌啶衍生物，涉及它们的制备方法，涉及它们用于治疗和/或预防疾病以及用于制备治疗和/或预防疾病的药物的用途，特别是用于治疗和/或预防糖尿病微血管病变、四肢糖尿病溃疡，特别是促进糖尿病足溃疡愈合、糖尿病心力衰竭、糖尿病冠状微血管心脏疾病、外周和心脏血管疾病、血栓栓塞疾病和缺血、外周循环障碍、雷诺现象、CREST综合征、微循环障碍、间歇性跛行以及外周和自主神经病变的治疗和/或预防。
• Carbon Dioxide-Mediated C(<i>sp</i>²)–H Arylation of Primary and Secondary Benzylamines
  作者：Mohit Kapoor、Pratibha Chand-Thakuri、Michael C. Young

  DOI：10.1021/jacs.9b03375

  日期：2019.5.15

  the pharmacological importance of ortho-arylbenzylamines, however, effective ortho-C-C bond formation of free primary and secondary benzylamines using PdII remains an outstanding challenge. Presented herein is a new strategy for constructing ortho-arylated primary and secondary benzylamines mediated by carbon dioxide (CO2). The use of CO2 with Pd is critical to allowing this transformation to proceed

  通过过渡金属催化的 CH 活化形成 CC 键已成为快速制造新键的重要策略。然而，尽管邻芳基苄胺具有药理学重要性，但使用 PdII 形成游离伯胺和仲苄胺的有效邻 CC 键仍然是一个突出的挑战。本文提出了一种用于构建由二氧化碳 (CO2) 介导的邻位芳基化伯和仲苄胺的新策略。CO2 与 Pd 的使用对于允许这种转化在相对温和的条件下进行至关重要，机械研究表明它 (CO2) 直接参与速率决定步骤。此外，较温和的温度提供了无需脱保护即可直接使用或加工的游离胺产品。
• One-Pot C–H Arylation/Lactamization Cascade Reaction of Free Benzylamines
  作者：Pratibha Chand-Thakuri、Vinod G. Landge、Mohit Kapoor、Michael C. Young

  DOI：10.1021/acs.joc.0c00542

  日期：2020.5.15

  ortho-arylation of benzylamines followed by in situ lactamization. This cascade sequence is enabled by the use of 2-iodobenzoates, which facilitates C-H arylation from the free amine under conditions that typically require an improved directing group approach. This reaction is characterized by a broad substrate scope with good functional group tolerance. The need for an ester versus carboxylic acid-functionalized

  已经开发出一种有效的方法，用于合成七元联芳基内酰胺，涉及钯催化的，天然胺导向的苄胺的正芳基化，然后进行原位内酰胺化。通过使用2-碘代苯甲酸酯使该级联序列成为可能，其在通常需要改进的导向基团方法的条件下促进游离胺的CH芳基化。该反应的特征在于底物范围广，具有良好的官能团耐受性。还探索了对酯对羧酸官能化的偶合剂的需求，以及合成八元联芳基内酰胺的潜力。还研究了各种应用，包括使用氮杂-油菜素内酯核心。
• [EN] N-HETEROARYLALKYL-2-(HETEROCYCLYL AND HETEROCYCLYLMETHYL) ACETAMIDE DERIVATIVES AS SSTR4 AGONISTS<br/>[FR] DÉRIVÉS DE N-HÉTÉROARYLALKYLE-2-(HÉTÉROCYCLYLE ET HÉTÉROCYCLYLMÉTHYLE) ACÉTAMIDE UTILISÉS EN TANT QU'AGONISTES DE SSTR4
  申请人：TAKEDA PHARMACEUTICALS CO

  公开号：WO2021202781A1

  公开（公告）日：2021-10-07

  Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein L, n, R1, R2, R6, R7, R8, R9, R10, X3, X4 and X5 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating diseases, disorders, and conditions associated with SSTR4.

  揭示了Formula 1的化合物及其药用盐，其中L、n、R1、R2、R6、R7、R8、R9、R10、X3、X4和X5在说明书中有定义。本公开还涉及制备Formula 1化合物的材料和方法，包含它们的药物组合物，以及它们用于治疗与SSTR4相关的疾病、疾患和症状的用途。
• NITROGEN-CONTAINING SATURATED HETEROCYCLIC COMPOUND
  申请人：SUMITOMO CHEMICAL COMPANY, LIMITED

  公开号：US20160221948A1

  公开（公告）日：2016-08-04

  The present invention provides a compound represented by the following formula (I) or its pharmaceutically acceptable salt: [wherein, R 1 represents optionally substituted C 1-4 alkyl, n shows integer of 1 to 4, R 2 represents optionally substituted C 1-4 alkyl or hydrogen atom, R 3 represents optionally substituted C 1-4 alkyl, R 4a , R 4b , R 4c , and R 4d , similarly or differently, represent optionally substituted C 6-14 aryl, optionally substituted C 1-4 alkyl, or hydrogen atom and the like, A represents optionally substituted C 6-14 aryl or optionally substituted 5 to 11 membered heteroaryl].

  本发明提供了一种由下式(I)表示的化合物或其药用可接受的盐： [其中，R1表示可选地取代的C1-4烷基，n表示1到4的整数，R2表示可选地取代的C1-4烷基或氢原子，R3表示可选地取代的C1-4烷基，R4a、R4b、R4c和R4d，相同或不同，表示可选地取代的C6-14芳基，可选地取代的C1-4烷基，或氢原子等，A表示可选地取代的C6-14芳基或可选地取代的5至11成员的杂芳基]。